Navigation Links
CONCERTA(R) (methylphenidate HCI) LAUNCHES MOBILE WEB EXPERIENCE TO PROVIDE TOOLS AND SUPPORT FOR ADHD AWARENESS
Date:9/9/2009

ers are believed to play a role in behaviors like attention and movement. Much like height or eye color, ADHD can be inherited. Studies suggest that 76 percent of ADHD is linked to family genetics. So the condition is more common among people who have a close relative with ADHD. Adults with ADHD have a 50 percent chance of passing it on to their children.

About CONCERTA((R))

CONCERTA((R)) is a prescription product approved for the treatment of attention deficit hyperactivity disorder (ADHD) as part of a total treatment program that may include counseling or other therapies.

IMPORTANT SAFETY INFORMATION

Talk to your healthcare professional for a proper diagnosis and treatment of ADHD. Only a healthcare professional can decide whether medication is right for you or your child.

CONCERTA((R)) should not be taken by patients who have: allergies to methylphenidate or other ingredients in CONCERTA((R)); significant anxiety, tension, or agitation; glaucoma; tics, Tourette's syndrome, or family history of Tourette's syndrome; current or past use of monoamine oxidase inhibitor (MAOI); esophagus, stomach, or intestinal narrowing. Children under 6 years of age should not take CONCERTA((R)).

Abuse of methylphenidate may lead to dependence. Tell your healthcare professional if you or your child has had problems with alcohol or drugs; has had any heart problems, heart defects, high blood pressure, or a family history of these problems; has had depression, abnormal thoughts or visions, bipolar disorder, or seizure. Contact your healthcare professional immediately if you or your child: develops abnormal thinking or hallucinations, abnormal or extreme moods and/or excessive activity; or if aggressive behavior or hostility develops or worsens while taking CONCERTA((R)). Your child's healthcare professional should check height and weight
'/>"/>

SOURCE McNeil Pediatrics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. District Court Decision Received in CONCERTA(R) Patent Case
2. Non-safety-related voluntary market withdrawal of a limited portion of DAYTRANA(R) (methylphenidate transdermal system) patches announced
3. Cumberland Pharmaceuticals Launches Caldolor(R) in the United States for Treatment of Pain and Fever
4. ICC Launches New Elpac Brand Convection Cooled 100-Watt Open Frame Power Supply
5. Bounty Parenting Club Launches View on Demand How to Breastfeed Video
6. Founder of Curidium Launches Elixior, an Advisory Company Focused on the Development and Growth of Innovative Personalized Medicine Businesses
7. Fairfield, New Jersey Cosmetic Dentistry Practice Launches State-of-the-art New Website
8. National Alliance on Mental Illness (NAMI Michigan) Launches TV Awareness Campaign
9. PRC Launches New Web Resource for Teaching Language to Children & Adults with Speech Disabilities
10. Rochester Medical Launches StrataSI(TM) & StrataNF(TM) Next Generation Foley Catheters
11. RBC Life Sciences Launches New Initiatives Aimed at Building Its Network Marketing Business Across North America
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... ... 02, 2015 , ... Cs &A, the leader in Semi ... release and publication of their newest offering to complement the existing line of ... , Designed in support of coverage for the full spectrum of Semi Timing ...
(Date:7/1/2015)... ... 2015 , ... A June 19th article by the Associated Press discussed a recent ... the cost of medical care, specifically for seniors. Medicare recently completed the first year of ... $25 million. Medicare’s chief medical officer, Dr. Patrick Conway said that “If we can keep ...
(Date:7/1/2015)... ATLANTA, GEORGIA (PRWEB) , ... July 01, 2015 ... ... the Institute for Biomedical Sciences at Georgia State University and a Georgia Research ... federal grant to develop novel anti-inflammatory therapeutics against middle-ear infections. , The grant ...
(Date:7/1/2015)... ... 01, 2015 , ... For decades, researchers in the genetics field have theorized ... brain, never changing after development in the womb. Now, researchers from the Icahn School ... cells throughout life – a process which helps to switch genes on and off. ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... care, specialty, combo, and compounding pharmacy operations, announces the most recent positioning of ... Cardinal Health RBC event at the Venetian Las Vegas, Nevada. During ...
Breaking Medicine News(10 mins):Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 2Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 3Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 4Health News:Article Announcing Medicare’s Cost Cutting Suggestions Shines Brightly on House Call Medicine, Comments Dr. Michael Farzam 2Health News:Article Announcing Medicare’s Cost Cutting Suggestions Shines Brightly on House Call Medicine, Comments Dr. Michael Farzam 3Health News:Institute for Biomedical Sciences Researcher Gets $1.6 Million to Develop Anti-Inflammatory Drug 2Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 2Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 3Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 4Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 2Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 3Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 4
... ... Association (DIA) will host Personalized Medicine: Biomarkers and Diagnostics in Drug Development, Regulatory Approval, ... ... 1, 2009 -- The Drug Information Association (DIA) will host Personalized ...
... , , Campaign depends ... , WASHINGTON, Sept. 1 The U.S. Department ... in the 4th annual Drug-Free Work Week, which will occur Oct. ... emphasizes the importance of drug-free workplace programs to help prevent workplace ...
... invasive procedure shaves off lesions, researchers say , TUESDAY, ... esophagus can be treated effectively by less invasive, organ-sparing ... is good news, as esophageal cancer arising from Barrett,s ... cancer in the United States, and 90 percent of ...
... be a way around the harsh skin toxicity associated with ... online this week in Cancer Biology and Therapy ... at Jefferson. Cetuximab (Erbitux) is a monoclonal antibody ... (EGFR). It is widely used to treat colorectal cancer and ...
... recent study published in the Journal of Cancer ... smoking and breast cancer. What makes this study unique ... and BRCA2 gene mutations, which predispose women to breast ... were excluded to allow researchers to concentrate on lifestyle ...
... , CHICAGO, Sept. 1 With so ... pavement more often in the hunt for a new job! The ... their face - during an interview is foot pain. "Plenty of ... AnkleNFootCenter.com. "And dress shoes are the worst, particularly for women," adds ...
Cached Medicine News:Health News:DIA Conference to Explore The Science and Scope of Personalized Medicine 2Health News:U.S. Labor Department announces dates for 4th annual Drug-Free Work Week 2Health News:New Therapy Spares Organ in Early Esophageal Cancer 2Health News:Prodrug could help curb skin toxicity related to EGFR-inhibiting cancer drugs 2Health News:Breast cancer: Risk increases for smokers and overweight women 2Health News:Hitting the Pavement? Make Sure Your Feet (And Your Shoes) Are Ready. 2
(Date:7/1/2015)... , July 1, 2015 Eli Lilly and Company ... the second quarter of 2015 on Thursday, July 23, 2015. ... with the investment community and media to further detail the ... at 9 a.m. EDT. Investors, media and the general public ... a link that will be posted on Lilly,s website at ...
(Date:7/1/2015)... 2015  goBalto, Inc., the leading provider of ... growth in serving pharmaceutical, biotech and CRO companies. ... clinical trials and restrain costs, but inefficiencies tied ... stalled these efforts," said Sujay Jadhav , ... has encouraged Industry leaders, to embrace cloud-based solutions. ...
(Date:7/1/2015)... DUBLIN , June 24, 2015 ... has announced the addition of the "2015 ... to their offering. This new 175-page ... market segments, including diabetes (strips and meters), pregnancy, ... dynamics, size, growth, regulatory requirements, technologies, and competitive ...
Breaking Medicine Technology:Lilly Confirms Date and Conference Call for Second-Quarter 2015 Financial Results Announcement 2goBalto Triples Sites Managed, Further Reinforcing Market Leadership Position 22015 Strategies in the Home/Self Testing Market 2
... 2011 The staffs of Chiltern International Limited (Chiltern), ... celebrate the 25 year mark of their successful collaboration ... and Spectratox have worked together using a validated and ... for the assessment of drug phototoxicity. The history of ...
... Feb. 28, 2011 The Coalition for Ethical Imaging ... diagnostic imaging practices in Texas, is supporting House Bill ... several initiatives that will help rein in healthcare costs ... CEI,s membership includes radiologists and other medical professionals, members ...
Cached Medicine Technology:Chiltern - Spectratox Drug Photoxicity Collaboration Celebrates 25 Years 2Chiltern - Spectratox Drug Photoxicity Collaboration Celebrates 25 Years 3Coalition for Ethical Imaging Advocates Diagnostic Imaging Reform in the 82nd Texas Legislature 2Coalition for Ethical Imaging Advocates Diagnostic Imaging Reform in the 82nd Texas Legislature 3
True/Fix Distal Femoral Nail System...
The OsteoJect Bone Cement Delivery System now offers leading technology to physicians with the first-ever reusable driver. The OsteoJect allows precise delivery of bone cement under active fluoro whi...
... to reduce noise to a minimum results ... less hearing trauma for the clinician. The ... power in a smaller, lighter package. In ... balance and ergonomics for more user comfort. ...
The three point staple, used for valgus tibial osteotomy, is easy and quick to fit, with a compact size compared with other existing systems....
Medicine Products: